Predictions
MorphoSys AG
Start price
Target price
Perf. (%)
€16.57
05.09.22
05.09.22
-
05.10.26
05.10.26
293.97%
11.03.24
11.03.24
Probably not worthwhile Investment
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€3.06
03.09.22
03.09.22
-
03.09.23
03.09.23
-86.05%
24.04.23
24.04.23
Risky Investment
Invitae Corp
Start price
Target price
Perf. (%)
€2.76
02.09.22
02.09.22
-
02.09.23
02.09.23
-10.51%
27.09.22
27.09.22
Could be very worthwhile Investment >20% year
Invitae Corp
Start price
Target price
Perf. (%)
€3.32
26.08.22
26.08.22
-
26.08.23
26.08.23
-17.03%
03.09.22
03.09.22
Could be very worthwhile Investment >20% year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€5.40
23.08.22
23.08.22
-
23.08.23
23.08.23
29.96%
09.09.22
09.09.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.50
21.08.22
21.08.22
€230.00
21.08.23
21.08.23
6.54%
04.09.22
04.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Invitae Corp
Start price
Target price
Perf. (%)
€3.50
21.08.22
21.08.22
€1.00
21.08.23
21.08.23
-21.28%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.50
16.08.22
16.08.22
-
16.08.23
16.08.23
-27.77%
16.08.23
16.08.23
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€104.86
16.08.22
16.08.22
-
16.08.23
16.08.23
-6.73%
16.08.23
16.08.23
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€64.36
10.08.22
10.08.22
-
10.08.23
10.08.23
6.49%
10.08.23
10.08.23
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.10
10.08.22
10.08.22
-
10.08.23
10.08.23
3.34%
10.08.23
10.08.23
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
08.08.22
08.08.22
-
08.08.26
08.08.26
-
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.91
03.08.22
03.08.22
€3.30
03.08.23
03.08.23
-12.37%
13.10.22
13.10.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Sartorius AG VZO
Start price
Target price
Perf. (%)
€418.20
22.07.22
22.07.22
€550.00
22.07.23
22.07.23
-23.00%
30.05.23
30.05.23
Invitae Corp
Start price
Target price
Perf. (%)
€2.86
12.07.22
12.07.22
€2.10
12.07.23
12.07.23
-54.35%
11.03.23
11.03.23
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€8.45
11.07.22
11.07.22
-
11.07.23
11.07.23
-39.77%
04.08.22
04.08.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected